Biogen Idec, Inc. (Massachusetts) Awards Clinical Fellowship Program Grants to Support Education and Research for the Treatment of Multiple Sclerosis

WESTON, Mass.--(BUSINESS WIRE)--As part of its commitment to furthering the quality of education in the field of multiple sclerosis (MS), Biogen Idec (NASDAQ: BIIB) is proud to announce that it provided grants to twelve prestigious universities and medical centers across the country for the 2010-2011 academic year. The grants were awarded through the Biogen Idec MS Clinical Fellowship Program and provided a total of $900,000 to recipients for the placement of clinical MS Fellows.

MORE ON THIS TOPIC